(R)-N-(1-Acryloylpiperidin-3-yl)-4-oxo-5-(o-tolyl)-4,5-dihydro-3H-1-thia-3,5,8-triazaacenaphthylene-2-carboxamide

ID: ALA4877611

PubChem CID: 129220053

Max Phase: Preclinical

Molecular Formula: C24H23N5O3S

Molecular Weight: 461.55

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C=CC(=O)N1CCC[C@@H](NC(=O)c2sc3nccc4c3c2NC(=O)N4c2ccccc2C)C1

Standard InChI:  InChI=1S/C24H23N5O3S/c1-3-18(30)28-12-6-8-15(13-28)26-22(31)21-20-19-17(10-11-25-23(19)33-21)29(24(32)27-20)16-9-5-4-7-14(16)2/h3-5,7,9-11,15H,1,6,8,12-13H2,2H3,(H,26,31)(H,27,32)/t15-/m1/s1

Standard InChI Key:  SXAJMFPTYRJJPY-OAHLLOKOSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   14.8040  -10.8134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8029  -11.6409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5177  -12.0537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2343  -11.6404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2314  -10.8098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5159  -10.4006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9471  -12.0510    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.3745  -12.0521    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.6589  -11.6362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9496  -12.8769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2414  -13.2842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2400  -14.1027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9526  -14.5123    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.6593  -14.1004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3763  -12.8794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6613  -13.2909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6523  -14.1854    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   18.9886  -13.4322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7959  -13.2617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3471  -13.8754    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.0518  -12.4773    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.8590  -12.3067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4060  -12.9236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2101  -12.7557    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4702  -11.9724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9197  -11.3565    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.1091  -11.5240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6584  -10.8112    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.1783  -10.5730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9862  -10.4052    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.6291   -9.9573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8877   -9.1738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5175  -12.8788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7 10  1  0
  7  9  1  0
 15  8  1  0
  8  9  1  0
  4  7  1  0
 16 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 16 14  1  0
 15 16  1  0
 17 18  1  0
 18 15  2  0
 17 14  1  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 22 21  1  1
 22 23  1  0
 22 27  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
  9 28  2  0
 26 29  1  0
 29 30  2  0
 29 31  1  0
 31 32  2  0
  3 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4877611

    ---

Associated Targets(Human)

BTK Tclin Tyrosine-protein kinase BTK (8973 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Btk Tyrosine-protein kinase BTK (130 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 461.55Molecular Weight (Monoisotopic): 461.1522AlogP: 4.20#Rotatable Bonds: 4
Polar Surface Area: 94.64Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 12.22CX Basic pKa: 0.39CX LogP: 3.53CX LogD: 3.53
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.57Np Likeness Score: -1.36

References

1. Tichenor MS, Wiener JJM, Rao NL, Pooley Deckhut C, Barbay JK, Kreutter KD, Bacani GM, Wei J, Chang L, Murrey HE, Wang W, Ahn K, Huber M, Rex E, Coe KJ, Wu J, Seierstad M, Bembenek SD, Leonard KA, Lebsack AD, Venable JD, Edwards JP..  (2021)  Discovery of a Potent and Selective Covalent Inhibitor of Bruton's Tyrosine Kinase with Oral Anti-Inflammatory Activity.,  12  (5.0): [PMID:34055226] [10.1021/acsmedchemlett.1c00044]

Source